Transcranial magnetic stimulation —
New brain imaging
tool
R. J. Ilmoniemi1,2,3
1BioMag
Laboratory, Engineering Centre, Helsinki University Central Hospital, P.O. Box
340, FIN-00029 HUS, Finland;
2Helsinki Brain Research Center, Helsinki, Finland;
3Nexstim Ltd., Elimäenkatu 22 B, FIN-00510 Helsinki, Finland
Abstract:
Recent advances in targeting
TMS on the basis of 3D MRI images and in combining it with EEG, PET, and fMRI
are transforming TMS into a new brain imaging modality. With MRI-based targeting
of the stimuli and the ability to measure cortical responses evoked by TMS,
one can perform precisely controlled studies on cortical reactivity and connectivity.
The new techniques will find applications in cognitive, neurological and psychiatric
studies and in therapy.
INTRODUCTION
The brain can be stimulated non-invasively by magnetic
field pulses that induce a flow of current in the tissue. This technique, called
transcranial magnetic stimulation (TMS), has grown dramatically in popularity
since its initial demonstration by Barker et al. in 1985 [1].
Initially, most TMS experiments were limited to
the stimulation of the motor cortex, because the only effects of the stimulation
that could be reliably observed were those reflected in muscular activity. In
the past few years, however, it has been demonstrated that one can observe the
cortical effects of TMS also directly, e.g., by means of electroencephalography
(EEG), positron emission tomography (PET), or functional magnetic resonance
imaging (fMRI).
These developments, together with the possibility
to target the stimuli on the basis of 3D MRI, are transforming TMS to a completely
new brain mapping modality, which is based on observing brain activity after
neurons have been triggered into action in a controlled fashion.
With TMS, one can 1) measure cortical excitability,
2) study the integrity, efficacy, and timing of area-to-area connections, 3)
find cortical areas that are important for specific tasks, or 4) treat patients.
The field strength of up to several tesla
required in TMS is produced by a strong current in a coil placed over the scalp.
The effect in the brain is due to the induced electric current and the consequent
depolarization of cell membranes.
The field strengths in TMS are lower than
or equal to the field in a typical modern MRI scanner; there is no reason to
believe that the direct effect of the magnetic field of a brief pulse would
be any more harmful than a static one, which itself appears to pose no danger.
Power dissipation due to the TMS-induced electrical currents is also low: the
total dissipated power in the brain during 20-Hz repetitive TMS (rTMS) is less
than 1 mW, i.e., several orders of magnitude less than the brain’s
metabolic power. After over a decade of intense scrutiny, TMS seems to be a
rather safe technique [2].
The focality of stimulation depends on the
type of coil and on its distance from the head, small coils pressed against
the scalp generally producing the most confined stimulation. In early magnetic
stimulators, only circular coils were used; better focus can be obtained with
the figure-of-eight coil [3]. In the future, we may see arrays of coils,
which allow further improved focusing as well as electronic targeting [4,5].
In traditional TMS studies, the coil is placed
over the head by using external landmarks or by trial and error until the desired
response (e.g., thumb twitch) is generated. In contrast, one can now
use navigated TMS, where the coil is positioned on the basis of MRI so that
one can define in advance which anatomical feature of the brain is stimulated.
Navigated TMS allows precise definition of the
induced electric field strength instead of choosing a percentage of the maximum
stimulator output or percentage of the motor threshold. The improved control
of stimulus parameters will improve reliability and safety.
TMS combined with multichannel EEG allows one to
monitor the spreading of neuronal activation after stimulation [6]. The main
advantage of concurrent TMS and EEG is the possibility to study cortical excitability
and functional connectivity on a millisecond scale [7].
Paus et al. [8] combined
TMS and PET, introducing a new technique that permits the mapping of neural
connections in the living human brain. While stimulating a selected cortical
area, they simultaneously measured changes in cerebral blood flow. They found
significant correlations between cerebral blood flow and the number of TMS pulse
trains, demonstrating functional connectivity from the left frontal eye field
to visual areas in the superior parietal and medial parieto-occipital cortex.
The use of TMS within an MRI equipment is not straightforward
because of the magnetic forces between the two systems and because the TMS coil
may distort the MRI images. Nevertheless, it has been shown that TMS-evoked
brain activation can be measured by using fMRI [9, 10].
RESULTS
A powerful TMS paradigm was introduced by Amassian
et al. [11]: a subject’s performance in a character identification task
was impaired when single magnetic pulses were administered between 60 and 140
ms after the onset of the visual stimulus; a temporary functional lesion had
been created. This technique has been subsequently used in a variety of experiments.
For example, Pascual-Leone et al. [12] showed that by applying rTMS to
language areas in the dominant hemisphere, speech production can be arrested.
Ziemann et al. [13]
studied effects of epileptic drugs on motor cortex excitability using TMS. Kähkönen
et al. [14] used TMS with high-resolution EEG to see how ethanol
affects TMS-evoked cortical activity. Stimulating the motor cortex in the left
hemisphere, they observed alcohol-induced changes not only in the stimulated
area, but also in the frontal cortex, including the contralateral hemisphere.
It thus appeared that ethanol had changed the functional connectivity between
motor and prefrontal cortices.
TMS is used increasingly for depression therapy.
George et al. [15] treated medication-resistant depressed patients by
applying rTMS to the left dorsolateral prefrontal cortex, where neuronal activity
appears to be lowered in depression. Several other authors [16] have subsequently
reported positive results on depressed patients, giving hope that rTMS may replace
the inconvenient electroconvulsive therapy (ECT) at least in some cases of drug-resistant
depression.
rTMS has also been an experimental treatment for
patients with obsessive-compulsive disorders [17], post-traumatic stress [18],
schizophrenia and Parkinson's disease [19]. However, the physiological mechanisms
and the conclusive demonstration of the efficacy of rTMS in therapy still requires
extensive clinical trials.
DISCUSSION
In its 16 years of existence, TMS has evolved into
a valuable technique for both clinicians and basic researchers. It is a unique
and powerful tool providing a means to examine cortical excitability and connectivity
in normal and abnormal human brain in vivo. On the other hand, rTMS has
shown promise as an alternative treatment in several psychiatric disorders,
in particular in depression. In cognitive neuroscience, the excellent temporal
resolution of TMS is invaluable in determining brain–behaviour relations with,
e.g., temporary lesion studies. Advances in precise, navigated targeting
of TMS, improved techniques for the recording of TMS-evoked activity, integration
with MRI and other imaging techniques, and new experimental paradigms and clinical
applications promise a bright future for TMS. One can say that a new brain imaging
tool has emerged.
Acknowledgments: Supported by the Academy
of Finland and Helsinki University Central Hospital Research Funds.
REFERENCES
[1] A.T. Barker, R. Jalinous, I.L. Freeston, “Non-invasive
magnetic stimulation of human motor cortex,” Lancet, vol. 1, pp. 1106–1107,
1985.
[2] E.M. Wassermann, “Risk and safety of repetitive
transcranial magnetic stimulation: report and suggested guidelines from the
International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation,
June 5–7, 1996,” Electroenceph. Clin. Neurophysiol., vol. 108, pp. 1–16,
1998.
[3] S. Ueno, T. Tashiro, and K. Harada, “Localized
stimulation of neural tissues in the brain by means of a paired configuration
of time-varying magnetic fields,” J. Appl. Phys., vol. 64, 5862–5864,
1988.
[4] R. Ilmoniemi and F. Grandori, Finnish Patent
No. 100458, 1997.
[5] J. Ruohonen and R.J. Ilmoniemi, “Focusing and
targeting of magnetic brain stimulation using multiple coils,” Med. Biol.
Eng. Comput., vol. 36, pp. 297–301, 1998.
[6] R.J. Ilmoniemi, J. Virtanen, J. Ruohonen et
al., “Neuronal responses to magnetic stimulation reveal cortical reactivity
and connectivity,” NeuroReport, vol. 8, 3537–3540, 1997.
[7] S. Komssi, H.J. Aronen, J. Huttunen, et al.,
“Ipsi- and contralateral EEG reactions to transcranial magnetic stimulation,”
Clin. Neurophysiol., vol. 113, 175–184, 2002.
[8] T. Paus, R. Jech, C.J. Thompson et al., “Transcranial
magnetic stimulation during positron emission tomography: A new method for studying
connectivity of the human cerebral cortex,” J. Neurosci., vol. 17, 3178–3184,
1997.
[9] O. Josephs, B.S. Athwal, C. Mackinnon et al.,
“Transcranial magnetic stimulation with simultaneous undistorted functional
magnetic resonance imaging,” NeuroImage, vol. 9, S124, 1999.
[10] D.E. Bohning, A. Shastri, E.M. Wassermann et
al., “BOLD-fMRI response to single-pulse transcranial magnetic stimulation (TMS),”
J. Magn. Reson. Imaging, vol. 11, 569–574, 2000.
[11] V.E. Amassian, R.Q. Cracco, P.J. Maccabee et
al., “Suppression of visual perception by magnetic coil stimulation of human
occipital cortex,” Electroenceph. Clin. Neurophysiol., vol. 74, 458–462,
1989.
[12] A. Pascual-Leone, J.R. Gates, and A. Dhuna,
“Induction of speech arrest and counting errors with rapid-rate transcranial
magnetic stimulation,” Neurology, vol. 41, 697–702, 1991.
[13] U. Ziemann, S. Lönnecker, B.J. Steinhoff et
al., “Effects of antiepileptic drugs on motor cortex excitability in humans:
a transcranial magnetic stimulation study,” Ann. Neurol., vol. 40, 367–378,
1996.
[14] S. Kähkönen, M. Kesäniemi, V.V. Nikouline et
al., “Ethanol modulates cortical activity: direct evidence with combined TMS
and EEG,” NeuroImage, vol. 12, 1649–1652, 2001.
[15] M.S. George, E.M. Wassermann, W.A. Williams
et al., “Daily repetitive transcranial magnetic stimulation (rTMS) improves
mood in depression,” NeuroReport, vol. 6, 1853–1856, 1995.
[16] A. Pascual-Leone, B. Rubio, F. Pallardo, et
al., “Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal
cortex in drug-resistant depression,” Lancet, vol. 348, 233–237, 1996.
[17] B.D. Greenberg, M.S. George, J.D. Martin et
al., “Effect of prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive
disorder: a preliminary study,” Am. J. Psychiatry, vol. 154, 867–869,
1997.
[18] U.D. McCann, T.A. Kimbrell, C.M. Morgan et
al., “Repetitive transcranial magnetic stimulation for posttraumatic stress
disorder,” Arch. Gen. Psychiatry, vol. 55, 276–279, 1998.
[19] A. Pascual-Leone and M.D. Catala, “Lasting
beneficial effect of rapid rate transcranial magnetic stimulation on slowness
in Parkinson's disease,” Neurology, vol. 45, 550, 1995.